Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-06T14:27:30.215Z Has data issue: false hasContentIssue false

Protein kinase A regulation of pigment granule motility in retinal pigment epithelial cells from fish, Lepomis spp.

Published online by Cambridge University Press:  15 September 2021

Nicole E. Leitner
Affiliation:
Department of Biology, Saint Joseph’s University, Philadelphia, Pennsylvania, USA
Christina King-Smith*
Affiliation:
Department of Biology, Saint Joseph’s University, Philadelphia, Pennsylvania, USA
*
*Corresponding author: Christina King-Smith, email: csmith@sju.edu
Rights & Permissions [Opens in a new window]

Abstract

Retinomotor movements include elongation and contraction of rod and cone photoreceptors, and mass migration of melanin-containing pigment granules (melanosomes) of the retinal pigment epithelium (RPE) within the eyes of fish, frogs, and other lower vertebrates. Eyes of these animals do not contain dilatable pupils; therefore the repositioning of the rods and cones and a moveable curtain of pigment granules serve to modulate light intensity within the eye. RPE from sunfish (Lepomis spp.) can be isolated from the eye and dissociated into single cells, allowing in vitro studies of the cytoskeletal and regulatory mechanisms of organelle movement. Pigment granule aggregation from distal tips of apical projections into the cell body can be triggered by the application of underivatized cAMP, and dispersion is effected by cAMP washout in the presence of dopamine. While the phenomenon of cAMP-dependent pigment granule aggregation in isolated RPE was described many years ago, whether cAMP acts through the canonical cAMP-PKA pathway to stimulate motility has never been demonstrated. Here, we show that pharmacological inhibition of PKA blocks pigment granule aggregation, and microinjection of protein kinase A catalytic subunit triggers pigment granule aggregation. Treatment with a cAMP agonist that activates the Rap GEF, Epac (Effector protein activated by cAMP), had no effect on pigment granule position. Taken together, these results confirm that cAMP activates RPE pigment granule motility by the canonical cAMP-PKA pathway. Isolated RPE cells labeled with antibodies against PKA RIIα and against PKA-phosphorylated serine/threonine amino acids show diffuse, punctate labeling throughout the RPE cell body and apical projections. Immunoblotting of RPE lysates using the anti-PKA substrate antibody demonstrated seven prominent bands; two bands in particular at 27 and 64 kD showed increased levels of phosphorylation in the presence of cAMP, indicating their phosphorylation could contribute to the pigment granule aggregation mechanism.

Information

Type
Research Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press
Figure 0

Fig. 1. Dissociated RPE cells from bluegill fish (Lepomis macrochirus). (A) RPE cell immediately after dissociation. (B,C) Dissociated RPE cell after settling and attachment. Slender, elongated pigment granules extend throughout the (formerly) apical projections. Cells in dopamine with dispersed pigment granules (phase bright) (B). Treatment with 1 mM cAMP triggers aggregation of pigment granules out of apical projections into the cell body (C). Bar: 10 μm.

Figure 1

Fig. 2. Effect of the protein kinase A inhibitor, H89, on pigment granule aggregation. (A) Control cell in 10 μM dopamine with dispersed pigment granules; (B) after cAMP treatment. Both dopamine- and cAMP controls included the carrier, 0.1% DMSO. (C) After cAMP plus 10 μM H-89. (D) Arcsine transformed pigment index data of treated cells. Open circles: dispersed (dopamine) or aggregated (cAMP) plus 0.1% DMSO. Closed circles: cAMP plus 1 or 10 μM H89. Results of a typical experiment; horizontal bar: mean, N = 30 cells per treatment. ****P < 0.0001; n.s., no significant difference (Welch’s ANOVA and Dunnett’s T3 test for multiple comparisons). The experiment was carried out three times. (E, left) Fragments of isolated retinal pigment epithelia sheets treated with dopamine or cAMP in 0.1% DMSO, or cAMP plus 10 μM H89. AP tip length (length of the distalmost part of apical projections that was devoid of pigment granules) was measured for each treatment. Asterisks: pigment granules dispersed at or near the tip of apical projections after dopamine treatment (phase bright regions, AP tip length ≈ 0). Arrowheads: distal portion of apical projections devoid of pigment granules (phase gray). (E, right) AP tip length for RPE sheets treated as in (D), results of a typical experiment. Mean ± S.E.M., N = 100–110 apical projections from 8 to 10 RPE sheet fragments for each treatment. *P < 0.05. The experiment was carried out three times. Bars: 10 μm (A–C), 20 μm (E).

Figure 2

Fig. 3. Effect of PKA catalytic subunit microinjection on isolated RPE cells. (A) RPE cells with dispersed pigment granules, before microinjection. (B) Twenty minutes after injection; pigment granules are mostly aggregated. (C) Neighboring, noninjected cells; pigment granules remain dispersed. (D) Control cell injected with FITC dextran only immediately after injection. (E) Twenty minutes after injection. Arrows indicate pigment granules that remained dispersed within apical projections. Bar: 10 μm.

Figure 3

Fig. 4. Dissociated RPE cells incubated in (A) 10 uM dopamine; (B) dopamine then 1 mM cAMP, (C) dopamine then 8CPT. (D) Arcsine transformed pigment index of treated cells, N = 30 cells per treatment. Horizontal line: mean. ****P < 0.0001; n.s., not significant. Results of a typical experiment. (E) AP tip length for RPE sheet fragments subjected to the same treatments. Mean ± S.E.M., N = 100–110 apical projection measurements for each treatment from 9 to 10 RPE sheet fragments. Results of a typical experiment. Each protocol (on isolated cells or RPE sheets) was carried out twice. Bar: 10 μm.

Figure 4

Fig. 5. Immunofluorescence of anti-RIIα labeling in isolated RPE cells having dispersed (A,B) or aggregated (C,D) pigment granules. Insets: rectangles in (A,B). Bar: 10 μm.

Figure 5

Fig. 6. Fluorescent antibody labeling of PKA-phosphorylated substrates in isolated RPE cells and corresponding phase contrast images. Cells were treated with dopamine to disperse pigment granules (A,D) or cAMP, to aggregate granules (B,C,E,F). Panels C,F no primary antibody. Bar: 10 μm.

Figure 6

Fig. 7. Identification of PKA-phosphorylated proteins in RPE. (A, top) Immunoblot of RPE lysates pretreated in dopamine or cAMP and probed with anti-phosphorylated PKA substrate antibodies; (bottom) same lanes as above, Ponceau-stained band showing total protein. Results from one experiment; note the dopamine lane had slightly more total protein than the cAMP lane (compare Ponceau bands for cAMP and dopamine). (B) Ratio of cAMP and dopamine band intensities for bands A–G in panel A normalized to the total protein in the lane using the 69 kD Ponceau-stained band (see section “Materials and methods”). Panel B includes data from four separate experiments; each experiment included both dopamine and cAMP-treated RPE pooled from 2 to 4 fish.

Leitner and King-Smith supplementary material

Leitner and King-Smith supplementary material

Download Leitner and King-Smith supplementary material(Video)
Video 29.3 MB